A monoclonal antibody, 14D9, which has been elicited against a cationic hapten, N-alkyl-N-methyl-3-glutarylamidomethyl piperidinium, in which alkyl = [4-(2-hydroxyethylamido)carbonylJphenylmethyl, is capable of inverting the intrimsic order ofreactivity in a series ofstructurally related enol ethers and ketals towards hydrolysis. The order of reactivity of compounds 2 (1-methoxy-2-alkylcyclopent-1-ene), 3 (1-methoxy-5-alkylcylopent-1-ene), and 4 (1,1-dimethoxy-2-alkylcyclopentane) has changed from 0.09:0.17:1 in the uncatalyzed reaction to 1100:25:1 under antibody catalysis. Also, the order of reactivity of the three chemically similar ketals, 6a (1-alkyl-2,2-dimethoxypropane), 6b (1-alkyl-1-methyl-2,2-dimethoxypropane), and 4, has changed from 0.23:0.38:1 in the uncatalyzed hydrolysis to 100:9:1 within the antibody active site. As all compounds bind the antibody with very similar affinities, these effects cannot be simply attributed to selective binding by the antibody. In fact, ketal 4, which shows no measurable catalysis, acts as a competitive inhibitor of 14D9-catalyzed hydrolysis of 6a. Both the solution and the antibodycatalyzed hydrolysis of the ketal substrates are shown to be specific acid catalyzed, involving the unimolecular cleavage of the protonated substrate or antibody-substrate complex in the rate-determining step. Reactivity effects from the acid catalyst itself on ketal hydrolysis (reagent-controlled reactivity) are ruled out under this mechanistic scheme.
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The essence of chemical catalysis is the ability not only to enhance the rate of a given reaction but also to achieve chemoselectivity, regioselectivity, and stereochemical control. It is now well established that reactions catalyzed by antibodies are likely to exhibit high levels of regio-and stereoselectivity (1). Chemoselectivity is particularly difficult to control because it involves selection of one out of several nearly equivalent reaction coordinates. An interesting example is the antibody-catalyzed chemoselective reduction of a diketone to a single enantiomer of hydroxyketone, which is essentially impossible to achieve by known chemical methods (2, t).
We now report on a remarkable case of chemoselectivity control by an antibody capable of catalyzing the hydrolysis of structurally similar ketals and enol ethers, all of which are shown to bind to the antibody active site with comparable affinity. The enol ether and ketal derivatives ofagiven ketone exhibit almost identical reactivity toward hydronium ioncatalyzed hydrolysis in water. Chemoselective activation of the ketal function in preference to the enol ether can be achieved with Lewis acids in anhydrous media (refs. 4 K2CO3 (829 mg, 6 mmol) in 19:1 acetone/dimethylformamide (20 ml) was refluxed for 12 h (step a). The solvent was removed under reduced pressure and the residue was dissolved in diethyl ether and washed with water. The organic layer was concentrated and dissolved in dimethyl sulfoxide (10 ml). Saturated aqueous NaCl (1 ml) was added and the tWe have reported on an alcohol dehydrogenase from Thermoanaerobium brockii that catalyzes the same type of transformation (3). As in the antibody-catalyzed reaction, the chemoselection reflects different binding affinities between the biocatalyst and the two carbonyl functions. §Reversal of chemoselectivity is a particularly intriguing challenge, as it involves modification of the intrinsic order of reactivity in a given series of functional groups. In some of the rare cases where reversal of chemoselectivity was achieved it involved change in mechanism. A classical example compares the relative reactivity of a primary bromide and an allylic acetate towards displacement by carbon nucleophiles. The allylic acetate, which is normally less reactive, becomes much more reactive when the reaction is catalyzed by Pd(0) (6).
mixture was refluxed for 6 h (step b), then mixed with water, extracted with ether, and purified by column chromatography (silica gel, hexane/ethyl acetate, 9:1, vol/vol) to give 4-(4-methoxycarbonyl)phenylbutan-2-one, 8a (620 mg, 60% A solution of 8a (206 mg, 1 mmol), p-toluenesulfonic acid (5 mg) in trimethyl orthoformate (5 ml), and methanol (5 ml) was stirred at room temperature for 2 h (step c). Saturated aqueous sodium bicarbonate was added and the mixture was extracted with dichloromethane to give 2,2-dimethoxy-4-(4-methoxycarbonyl)phenylbutane, 9a, which was taken to next step without further purification. 'H NMR (C2HCl3) ) was allowed to react with methyl (4-bromomethyl)benzoate (1.15 g, 5 mmol) as described above. The crude product was added to a mixture of HBr (48%, 10 ml) and conc. H2SO4 (2 ml), refluxed for 2 h, and then worked up with water and ether. The organic layer was concentrated, dissolved in methanol (10 ml) and conc. H2SO4 (0.2 ml), and refluxed for 16 h (step b' in Scheme I). Solvents were removed under reduced pressure, water was added, and the mixture was extracted with ether. Chromatographic purification (silica gel, hexane/ethyl acetate, 9:1) afforded 3-methyl-4-(4-methoxycarbonyl)phenylbutan-2-one, 8b (605 mg, 55% [bis(2-hydroxyethyl)amino]tris(hydroxymethyl)methane (Bistris) buffer (50 mM, pH 7.0) and one of the following: (i) NaCl (100 mM), (ii) NaCl (50 mM) and RCO2Na (50 mM), (iii) RCO2Na (100 mM). The following sodium carboxylates were used (R, pKa): CNCH2, 2.47; CICH2, 2.87; CH30CH2, 3.57; H, 3.75; HOCH2, 3.83; CH3, 4.76; and CH3CH2, 4.88. All solutions were then adjusted to pH 7.0. Product formation in these solutions of identical pH was monitored by HPLC and the data were interpreted in terms of first-order kinetics. In the case of 2, the observed rate enhancement in solutions ii and iii, as compared with i, varied from 1.25-(with 50 mM cyanoacetate) to 10-fold (with 100 mM propionate) and was found to be directly proportional to the concentration of the carboxylate. The Br0nsted coefficient (0.67) was obtained by plotting the logarithm ofthe rate constant for each carboxylic acid vs. its pKa. In the case of ketals 4 and 6a no measurable rate enhancement could be detected in reactions carried out under the same set of conditions. RESULTS AND DISCUSSION Monoclonal antibodies which have been elicited against hapten la were found to catalyze acid-promoted hydrolytic reactions, such as cleavage of a cyclic acetal (Eq. 1) (9), enantioselective hydrolysis of an epoxide (Eq. 2) (10), and enantioselective protonolysis of an enol ether (Eq. 3) (11). is-Menten kinetics and from the fact that catalysis is totally inhibited in the presence of stoichiometric quantities (with respect to 14D9) of the inhibitor lb (10). At 0°C and pH 7.55, the order of reactivity of the three chemically similar ketals 6a, 6b, and 4 toward hydrolysis is 0.23:0.38:1. However, this order is reversed to 100:9:1 within the antibody active site.
Remarkably, all three ketals show very similar affinity to 14D9. The Km values of substrates 6a and 6b are comparable (Table 1) . Moreover, ketal 4, which shows no measurable catalysis, acts as a competitive inhibitor of 14D9-catalyzed hydrolysis of6a with Ki = 35 ,uM. The corresponding Ki value for 6b is 60 ,uM (Fig. 2) .
The hydrolysis of enol ethers, such as 2 and 3, involves proton transfer from the acid catalyst to the carbon atom in the rate-determining step and is catalyzed by general acids (mechanism b in Scheme II) (8) . By contrast, hydrolysis of ketals, such as 4, proceeds by a rapid pre-equilibrium protonation of the ketal oxygen followed by rate-determining heterolysis of the carbon oxygen bond (specific acid catalysis, mechanism a in Scheme II). Thus, the hydrolysis rates of 4, 6a, and 6b are not affected by general acids and depend on the pH only. Accordingly, the selectivity of antibody 14D9 for 2 and 3 over 4 could be attributed to the presence of a protein side chain acting as a general acid in the active site. However, the observation of a catalytic reaction with ketals 6a and 6b clearly demonstrates that 14D9 can hydrolyze All reactions were carried out at 0°C in 50 mM phosphate/100 mM NaCl at pH 7.55 and 0°C. *Inhibition constants (Ko for competitive inhibition of 14D9-catalyzed hydrolysis of 6a were measured in 50 mM phosphate/100 mM NaCl at pH 7.55 and 0°C.
tNo rate enhancement could be detected.
ketals closely related to 4 despite the fact that these compounds are totally unreactive towards general acids. A large inverse kinetic solvent isotope effect is observed for the 14D9-catalyzed hydrolysis of ketal 6a: (kD/kH)cat = 2.4. This value is similar to the isotope effect for the uncatalyzed reaction with hydronium ion: (kD/kH)Xmat = 2.5. These values are consistent with specific acid catalysis (mechanism a in Scheme H). A similarly large, inverse solvent isotope effect (kD/kH = 2.82) has been reported for the hydronium ioncatalyzed hydrolysis of 2-ethoxytetrahydropyran (15). General acid catalysis in acetal/ketal hydrolysis has been observed either in cases where the leaving group is highly reactive-e.g., with 2-(p-nitrophenoxy)tetrahydropyran, for which kD/kH = 1.33 was measured for the hydronium ion catalysis (15)-or when the oxocarbonium intermediate is highly stable-e.g., in the case of tropone diethyl ketal (13). In the two special cases mentioned above, a significant pH-independent hydrolysis was also observed, in conjunction with general acid catalysis. We measured the pH-rate profile for the background hydrolysis of ketals 4 and 6a between pH 6.0 and 10.0 {50 mM 1,3-bis[tris(hydroxymethyl)methylamino]propane (Bistrispropane)/100 mM NaCl} and found that hydrolysis rates of both compounds are proportional to the hydronium ion concentration [slope of -1 for log(kuncat) vs detectable pH-independent component. This reinforces previous observations that our ketal substrates, despite their high hydrolysis rates in water, display normal reactivity and undergo hydrolysis under specific acid catalysis only.
CONCLUSION
The ability to control chemoselectivity by chemical catalysis represents one of the chemist's main goals. We presented here two examples of reversal of chemoselectivity that were achieved under antibody catalysis: (i) activation of enol ethers in the presence of a ketal and (ii) inversion of the order of reactivity in structurally similar ketals. Since all compounds involved in this study bind the antibody with very similar affinities and are structurally related, these effects cannot simply be attributed to selective binding by the antibody or to the placement of the reactive functionality away from the catalytically active site. The observed chemoselectivity might reflect conformational constraints on the ketal cleavage process within the antibody binding site. These observations may prove useful in future design of selective biocatalysts.
